Safety and efficacy of extracorporeal shockwave therapy on chronic prostatitis/chronic pelvic pain syndrome: a prospective, randomized, double-blind, placebo-controlled study
Author:
Funder
Ministry of Food and Drug Safety
Ministry of Trade, Industry and Energy
Ministry of Science, ICT and Future Planning
Ministry of Health and Welfare
Publisher
Elsevier BV
Reference15 articles.
1. Long term efficacy of extracorporeal shock wave therapy [ESWT] for treatment of refractory chronic abacterial prostatitis;Al Edwan;Ann Med Surg,2017
2. Diagnosis and treatment of chronic bacterial prostatitis and chronic prostatitis/chronic pelvic pain syndrome: a consensus guideline;Rees;BJU Int,2015
3. Efficacy and safety of extracorporeal shockwave therapy for the treatment of chronic non-bacterial prostatitis: a systematic review and meta-analysis;Birowo;PLoS One,2020
4. Association between predictors of progression of benign prostatic hyperplasia and moderate-to-severe prostatitis-like symptoms: a propensity score–matched analysis;Lee;Prostate Int,2022
5. Efficacy of low-intensity extracorporeal shock wave therapy for the treatment of chronic pelvic pain syndrome IIIb: a prospective-randomized, double-blind, placebo-controlled study;Kim;World J Mens Health,2022
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3